Clinical trials
Not yet recruiting Phase 2 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 12 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Cancer Hospital & Institute | 4 |
| Fujian Cancer Hospital | 3 |
| China Medical University, China | 2 |
| Hunan Province Tumor Hospital | 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | 2 |
| Yayi He | 2 |
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 1 |
| Beijing Chest Hospital, Capital Medical University | 1 |
| Dana-Farber Cancer Institute | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 34 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Recurrence | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.